EGFR and cancer: Importantly, GO and KEGG analysis revealed that Prx4 was enriched to several critical pathways which are widely recognized to be included in cancer progression, including rap1 signaling, hippo signaling, JAK-STAT signaling, MAPK signaling, ErbB signaling, and other key pathways.